Skip to content

CeriBell, Inc. CBLL Debt-to-equity

Debt-to-equity at other companies

IAR
Integra LifeSciencesIART
1.9×+0.6×
ClearPoint Neuro logo
ClearPoint NeuroCLPT
3.4×+3.2×
iRadimed logo
iRadimedIRMD
0.0×
Teladoc Health logo
Teladoc HealthTDOC
-0.4×
Cerence Inc. logo
Cerence Inc.CRNC
1.2×-0.7×
iRhythm Holdings, Inc.
 logo
iRhythm Holdings, Inc. IRTC
0.5×-0.5×

Other financials

Income statement

See full
Revenue$26.5M+29.3%
Gross profit$23.1M+28.4%
Operating income-$20.7M-46.0%
Net income-$19.7M-54.5%
EPS (diluted)-$0.52-44.4%

Balance sheet

See full
Cash & equivalents$45.3M-70.5%
Total debt$22.1M+1.6%
Total equity$140.8M-22.2%
Total assets$178.1M-16.6%

Cash flow

See full
Operating cash flow-$19.3M-69.2%
CapEx$125.0K-15.5%
Free cash flow-$19.4M-68.1%

Valuation

See full
Market cap$748.61M+15.6%
Enterprise value$725.47M+40.7%
P/S7.9×-1.2×

Profitability

See full
Gross margin87.7%+0.5pp
Operating margin-68.3%+5.5pp
Net margin-63.5%+1.0pp
FCF margin-52%-1.4pp

Returns & leverage

See full
Return on equity-37.5%
Current ratio10.4×-6.9×

Where this comes from

Calculated from CeriBell, Inc.’s reported figures.

Based on the most recent quarter.

The official record: CeriBell, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about CeriBell, Inc.'s debt-to-equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is CeriBell, Inc.'s debt-to-equity?
CeriBell, Inc. (CBLL) reported debt-to-equity of 0.2× in Q1 2026.
How has CeriBell, Inc.'s debt-to-equity changed year-over-year?
CeriBell, Inc.'s debt-to-equity increased by 30.6% year-over-year, from 0.1× to 0.2×.
What does debt-to-equity mean?
Total debt (including capitalized leases and financing obligations) divided by shareholders' equity at the quarter end. Measures how much the company is financed by debt relative to equity.